名仕快相(08483.HK)擬於香港開展醫療業務 委任陳永樂醫生為執行董事
格隆匯9月6日丨名仕快相(08483.HK)宣佈,(i)集團擬透過在香港經營診所及/或醫療中心開展醫療業務("醫療業務");及(ii)陳永樂已獲委任為執行董事,自2021年9月6日起生效。
董事會一直積極探索其他商機,以使集團現有業務(即yu 香港及廣東省不同地點的自助身份證明照片數碼快相機提供攝影服務)多元化及為公司股東帶來更高回報。鑑於香港日漸增強的健康意識及醫療服務需求,集團擬透過在香港經營診所及╱或醫療中心開展醫療業務。截至公吿日期,公司已新註冊成立三間全資附屬公司,即(i)Max Sight Healthcare Management Services (BVI) Limited(一間根據英屬處女羣島法律註冊成立的公司)、(ii)名仕醫療管理有限公司(一間根據香港法例註冊成立的公司,負責管理醫療業務)及(iii)名仕醫療服務有限公司(一間根據香港法例註冊成立的公司,負責診所及╱或醫療中心的日常營運),以之作為集團的醫療業務分支。公司現亦正招聘及物色合適的醫療從業員及處所,以資啟動醫療業務。公司現時目標為於2021年年底前在香港開設三間診所╱醫療中心。為籌備發展醫療業務,公司已委任於醫療行業累積豐富經驗的陳醫生擔任執行董事。陳醫生亦獲委任為名仕醫療服務有限公司之董事及醫療行政總監,主要負責集團醫療業務之發展。
董事會認為,發展醫療業務將使集團能夠憑藉陳永樂於醫療行業之專業知識及網絡,擴充業務組合、令收入來源多元化、擴闊收益基礎,及可能改善財務表現。因此,董事會認為,潛在新業務發展將符合公司及股東之整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.